Generic Drugs Price-Fixing Settlements — Complete Guide to Every Program, Website, and How to File
By Steve Levine
Published: March 8, 2026 (Updated)
Combined Settlement Total: Over $850,000,000
Claim Form Status: Not Yet Open (Registration Only)
Can I File a Claim Right Now?
No. As of March 2026, there are no claim forms open on any of the generic drugs settlement websites. You cannot submit a claim or receive a payment yet. Both the End-Payer program and the AG consumer program are only accepting email registrations so you can be notified when the claims process begins. If you think you may qualify, the best thing you can do right now is register on both official websites so you do not miss the claim window when it opens.Register on the AG Consumer Site
Register on the End-Payer Site
Why Are There So Many Different Websites?
This is the number one question people have, and the answer is simple once you understand it: there are multiple websites because there are multiple separate legal programs all dealing with the same underlying problem — generic drug companies allegedly conspired to fix prices — but through different legal channels.Think of it like this. Imagine a car company got caught overcharging millions of people. The state attorneys general might file their own lawsuits in one court. A separate group of consumer lawyers might file a class action in a different court. And the pharmacies and wholesalers who bought those cars might file their own case in yet another court. Each of those cases ends up with its own settlement, its own website, its own timeline, and its own claim form. That is exactly what happened here with generic drugs.
There are three main programs. Here is what each one does and who it is for:
Program 1: The AG Consumer Site (AGGenericDrugs.com)
Website: AGGenericDrugs.comWho it is for: Individual consumers — regular people who personally bought generic prescription drugs.
Who runs it: A coalition of 48+ State Attorneys General, led by Connecticut.
Claim form available? Not yet. Registration only.
This is the program most individual consumers will use. It is run by state attorneys general from nearly every state in the country. If you personally went to a pharmacy and paid for a generic prescription drug between May 2009 and December 2019, this is likely your program.
The AG program has settled with four companies so far: Apotex ($39.1 million), Heritage ($10 million), Bausch ($4.08 million), and Lannett ($13.77 million), for a combined total of about $66.95 million in the AG track alone. The Bausch and Lannett settlements received preliminary court approval on February 28, 2026. The deadline to exclude yourself or object to the Bausch/Lannett settlements is May 6, 2026, and the final approval hearing is May 27, 2026 in the U.S. District Court for the District of Connecticut.
The AG program website has a complete drug list you can check to see if any medications you purchased are covered.
Program 2: The End-Payer Site (GenericDrugsEndPayerSettlement.com)
Website: GenericDrugsEndPayerSettlement.comWho it is for: "End-payers" — consumers who paid for drugs, AND health insurers, employer plans, and union benefit plans that reimbursed drug costs.
Who runs it: Class action attorneys in the federal MDL (In re Generic Pharmaceuticals Pricing Antitrust Litigation, No. 16-MD-2724, E.D. Pa.).
Claim form available? Not yet. Registration only.
This is the federal class action program. It covers the same underlying price-fixing allegations but through a separate legal case in federal court. The word "End-Payer" just means anyone who ultimately paid for a covered drug — either you personally, or an insurance company or employer plan that paid on your behalf.
The End-Payer program has multiple settlement groups, each with its own page on the site: Apotex/Heritage classes, Sun/Taro classes (preliminary approval granted, fairness hearing was January 15, 2026), Sandoz ($275 million — the largest single settlement in this litigation, announced March 2025), and Certified Litigation classes (still in active litigation against remaining defendants).
A consumer could potentially qualify for both the AG program and the End-Payer program depending on which drugs they bought and which manufacturers are involved. These are separate legal programs and filing on one does not automatically file you on the other.
Program 3: The Direct Purchaser Site (GenericDrugsDirectPurchaserSettlement.com)
Website: GenericDrugsDirectPurchaserSettlement.comWho it is for: Direct purchasers — pharmacies, wholesalers, and distributors that bought drugs directly from the manufacturers.
Claim form available? Not applicable for most consumers.
This site is not for regular consumers. It is for businesses that bought generic drugs directly from manufacturers (not from a pharmacy or retailer). If you are a regular person who bought prescriptions at a pharmacy, this site will redirect you to the End-Payer site.
Quick Comparison: Which Site Is for You?
| Website | Who It Is For | Run By | Claim Form Open? |
|---|---|---|---|
| AGGenericDrugs.com | Individual consumers who bought generic Rx drugs | 48+ State Attorneys General | No — register for updates |
| GenericDrugsEndPayerSettlement.com | Consumers AND insurers/employer health plans | Federal class action attorneys (MDL, E.D. Pa.) | No — register for updates |
| GenericDrugsDirectPurchaserSettlement.com | Pharmacies, wholesalers, distributors only | Direct purchaser class attorneys | Not for consumers |
What Is This Case About?
Dozens of generic drug manufacturers are accused of conspiring to fix the prices of hundreds of commonly used prescription medications between 2009 and 2019. Instead of competing against each other to offer the lowest price — which is how generic drugs are supposed to work — these companies allegedly coordinated to keep prices artificially high, divvy up market share, and avoid undercutting each other. The result was that millions of Americans and their health insurance plans paid more than they should have for everyday medications like antibiotics, blood pressure drugs, antidepressants, diabetes medications, and thyroid treatments.The litigation is massive. It involves over 60 named corporate defendants, 25 individual executives, and hundreds of generic drugs. State attorneys general from nearly every state in the country filed three separate complaints. The federal class action was consolidated into a Multi-District Litigation (MDL) in the Eastern District of Pennsylvania. Settlements have been reached with some companies, while litigation continues against many others. The first trial is expected in late 2026 in Hartford, Connecticut.
How Much Money Is in These Settlements?
The combined settlement total across all programs is now over $850 million. Here is the breakdown by program:| Settlement | Program | Amount | Status |
|---|---|---|---|
| Sandoz / Fougera | End-Payer | $275,000,000 | Preliminary approval (March 2025) |
| Apotex / Heritage | End-Payer | Undisclosed (separate from AG amounts) | Preliminary approval |
| Sun / Taro | End-Payer | Undisclosed | Fairness hearing Jan 15, 2026 |
| Apotex | AG Consumer | $39,100,000 | Approved (Nov 2024) |
| Heritage | AG Consumer | $10,000,000 | Approved (Nov 2024) |
| Bausch | AG Consumer | $4,080,000 | Preliminary approval (Feb 28, 2026) |
| Lannett | AG Consumer | $13,770,000 | Preliminary approval (Feb 28, 2026) |
Many other defendants — including Teva, Actavis, Amneal, Lupin, Mallinckrodt, Mylan (now Viatris), Pfizer, and others — remain in active litigation and have not yet settled. In February 2026, 42 states filed a new lawsuit against Novartis and its subsidiaries Sandoz Group AG and Sandoz AG alleging a separate campaign to fix prices for 31 additional generic drugs. Additional settlements are expected over time.
Who Qualifies?
You may be eligible if you purchased, paid for, or reimbursed the cost of certain generic prescription drugs in the United States between May 1, 2009 and December 31, 2019. This includes individual consumers who personally paid for prescriptions at a pharmacy (out of pocket, copay, or coinsurance), health insurance companies that reimbursed drug costs, and employer health plans or union benefit plans that paid for prescription drug coverage.The specific drugs covered include hundreds of common generics. Some of the most well-known medications on the list include Albuterol (asthma), Amitriptyline (antidepressant), Amoxicillin (antibiotic), Amlodipine (blood pressure), Digoxin (heart), Doxycycline (antibiotic), Furosemide (diuretic), Glyburide and Glipizide (diabetes), Levothyroxine (thyroid), Lisinopril (blood pressure), Metoprolol (blood pressure/heart), Pravastatin (cholesterol), Sertraline (antidepressant), and Warfarin (blood thinner). This is not a complete list — check the official AG drug list for the full inventory.
When Will Claim Forms Be Available?
No specific date has been announced by either program. The AG consumer site says claims will open after final court approvals and that registrants will be notified by email. The End-Payer site says the claims process will open at a later date.The nearest milestone is the Bausch/Lannett AG settlement, which has a final approval hearing on May 27, 2026. The exclusion and objection deadline for that settlement is May 6, 2026. Even after final approval, it typically takes additional months before claim forms are launched and payments are distributed.
The AG program appears to be waiting to accumulate money from multiple settlements before opening claims, so that distributions can be larger and more efficient. The End-Payer program is following a similar approach. Both programs have said they will notify registrants when claim forms are available.
Do I Need to File Separate Claims on Each Site?
Yes. If you qualify under both the AG consumer program and the End-Payer federal class action, you would need to file separate claims on each site when the time comes. Filing on one site does not automatically count as a claim on the other. They are independent legal programs with different rules, timelines, and claim processes.Within the End-Payer program, each settlement group (Apotex/Heritage, Sun/Taro, Sandoz) will also have its own claim form. You may need to file a separate claim for each group depending on which drugs you purchased and which manufacturers made them.
What Should I Do Right Now?
Register on both official websites so you will be emailed when claim forms become available. You do not need to register on both sites to preserve your rights — you are automatically included in the settlement classes unless you choose to opt out — but registering ensures you will not miss the claim window.AG Consumer Program: Register here or call 1-866-290-0182
End-Payer Program: Register here or call 1-877-316-0171
If you already registered on either site, you do not need to register again.
While you wait, gather any pharmacy records, prescription receipts, insurance explanation of benefits (EOB) statements, or other documentation showing which generic drugs you purchased and when. This information may be needed when claim forms open.
Important Dates
Bausch/Lannett AG Exclusion/Objection Deadline: May 6, 2026
Bausch/Lannett AG Final Approval Hearing: May 27, 2026 (U.S. District Court, District of Connecticut)
First Trial (State AG cases): Expected late 2026, Hartford, Connecticut
Claim Form Launch (both programs): Date TBD — register for updates
February 2026 Update: Bausch, Lannett, and the New Novartis Lawsuit
On February 2, 2026, a coalition of 48 states and territories announced two new AG settlements with Lannett Company Inc. ($13.77 million) and Bausch Health ($4.08 million), totaling $17.85 million. Both companies agreed to cooperate with the ongoing litigation against 30 remaining corporate defendants and 25 individual executives. Both companies also agreed to implement antitrust compliance programs with annual training for sales and management staff.On the same day, 42 states and territories filed a brand new lawsuit against Novartis AG and its subsidiaries Sandoz Group AG and Sandoz AG. The complaint alleges Novartis ran a campaign to conspire with other generic manufacturers to fix prices, allocate markets, and rig bids for 31 different generic drugs. The complaint also alleges Novartis fraudulently transferred and drained assets from Sandoz Inc. — a separate entity already named as a defendant in the existing cases — and spun off Sandoz to shield Novartis from liability.
Case Information
Federal MDL: In re Generic Pharmaceuticals Pricing Antitrust Litigation, No. 16-MD-2724 (E.D. Pa.)
AG Cases: Three complaints filed by 48+ state AGs in the U.S. District Court for the District of Connecticut
Combined Settlement Total: Over $850 million across all programs
Class Period: May 1, 2009 to December 31, 2019 (varies by settlement)
Drugs Covered: Hundreds of common generics — see full list
End-Payer Class Counsel: Fine, Kaplan and Black, R.P.C.
How Do I Find Class Action Settlements?
Find all the latest class actions you can qualify for by getting notified of new lawsuits as soon as they are open to claims:Official Program Links
| Program | Link |
|---|---|
| AG Consumer Main Site | AGGenericDrugs.com |
| AG Registration | Register for Updates |
| AG Drug List | Check Covered Drugs |
| AG FAQ | Frequently Asked Questions |
| End-Payer Main Site | GenericDrugsEndPayerSettlement.com |
| End-Payer: Apotex/Heritage | Apotex/Heritage Classes |
| End-Payer: Sun/Taro | Sun/Taro Classes |
| End-Payer: Certified Litigation | Certified Litigation Classes |
| Direct Purchaser Site | GenericDrugsDirectPurchaserSettlement.com (not for consumers) |
Sources
• GenericDrugsEndPayerSettlement.com (official End-Payer site)• AGGenericDrugs.com (official AG consumer site)
• NY Attorney General — Bausch/Lannett Settlement Announcement (Feb 2026)
• CT Attorney General — Bausch/Lannett Settlement and Novartis Lawsuit (Feb 2026)
• PR Newswire — $275M Sandoz End-Payer Settlement Announcement (March 2025)
Filing Class Action Settlement Claims
Please note that your claim form will be rejected if you submit a settlement claim with any fraudulent information. By providing this information and your sworn statement of its veracity, you agree to do so under the penalty of perjury. If you are not sure whether you qualify, visit the program's official page for your class. OpenClassActions.com is a consumer advocacy and class action news site, and is not a class action administrator or a law firm.
For more class actions keep scrolling below.
Bayer RoundUp Bug Spray Lawsuits
Status: Open to Claims
Submit Claim
Video Game Addiction Lawsuit
Deadline: Pending
Submit Claim
DraftKings & FanDuel Addiction Lawsuits
Status: Open
Submit Claim
Children playing Roblox and using Discord?
Pre-Qualify Here
Submit Claim
$4.17M RevitaLash Conditioner Settlement
Deadline: April 20, 2026
Submit Claim
$87.5M Beef Prices Settlement
Deadline: June 30, 2026
Submit Claim
Dollar General Bait & Switch Settlement
Deadline: April 13, 2026
Submit Claim
$7.25 Billion RoundUp Bug Spray Settlement
Deadline: Pending
Learn More
Belkin Power Bank Settlement
Deadline: March 30, 2026
Submit Claim
$4.85M Bayer Antifungal Spray Settlement
Deadline: March 11, 2026
Submit Claim
Michael Kors Outlet Class Action Settlement
Deadline: March 20, 2026
Submit Claim
Balance of Nature $9.95M Class Action
Deadline: March 11, 2026
Submit Claim
Depo Provera Investigation
Deadline: Pending
Pre-Qualify| Generic Drugs Price-Fixing Settlement Summary | |
| Status | Open — Registration Only (No Claim Forms Yet) |
|---|---|
| Claim Deadline | TBD — register for updates |
| Bausch/Lannett Opt-Out Deadline | May 6, 2026 |
| Bausch/Lannett Hearing | May 27, 2026 (D. Conn.) |
| Combined Settlement Total | Over $850 million across all programs |
| Purchase Period | May 1, 2009 – December 31, 2019 |
| Who Qualifies | Consumers, insurers, and employer plans who paid for covered generic Rx drugs |
| AG Consumer Site | AGGenericDrugs.com |
| End-Payer Site | Generic Drugs EndPayer Settlement |